Rchr
J-GLOBAL ID：201801009788868672
Update date: Jul. 17, 2024
Michihisa Iida
イイダ ミチヒサ | Michihisa Iida
Affiliation and department：
Research field (1)：
Digestive surgery
Research keywords (4)：
gastric cancer
, miRNA
, tumor microenviroment
, colorectal cancer
Research theme for competitive and other funds (6)：
- 2023 - 2026 乳癌患者由来オルガノイドを用いた抗癌剤耐性機構の解明
- 2021 - 2024 大腸癌肝転移に関与する癌細胞由来マイクロRNAの同定と制御するメカニズムの解明
- 2018 - 2021 Prediction of anti-PD-1 antibody treatment for gastric cancer
- 2017 - 2020 Analysis of microRNA in cancer microenvironment involved in colorectal liver metastasis
- 2013 - 2016 Overexpression of MCM 6 in hepatocellular carcinoma and its potential as a prognostic marker.
- 2010 - 2011 Over-expression of the RD RNA binding protein is associated with portal vein invasion in hepatocellular carcinoma.
Show all
Papers (600)：
-
Yoshitaro Shindo, Tatsuya Ioka, Yukio Tokumitsu, Hiroto Matsui, Masao Nakajima, Yuta Kimura, Yusaku Watanabe, Shinobu Tomochika, Yuki Nakagami, Ryouichi Tsunedomi, et al. Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. Cancers. 2024. 16. 14. 2522-2522
-
Michihisa Iida, Shigeru Takeda, Tsunenori Yamamoto, Chiyo Nakashima, Mitsuo Nishiyama, Yusaku Watanabe, Yoshitaro Shindo, Yukio Tokumitsu, Shinobu Tomochika, Yuki Nakagami, et al. Risk factors for infectious complications after gastrectomy in older patients. Experimental and Therapeutic Medicine. 2024. 28. 2
-
Kei Furuya, Masao Nakajima, Ryouichi Tsunedomi, Yuki Nakagami, Ming Xu, Hiroto Matsui, Yukio Tokumitsu, Yoshitaro Shindo, Yusaku Watanabe, Shinobu Tomochika, et al. High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer. BMC cancer. 2024. 24. 1. 165-165
-
Junya Kondo, Shigefumi Yoshino, Michihisa Iida, Shigeru Takeda, Chiyo Nakashima, Yusaku Watanabe, Mitsuo Nishiyama, Yukio Tokumitsu, Yoshitaro Shindo, Taku Nishimura, et al. Effects of Extended Fixation on Advanced Gastric Cancer HER2 Status Assessment Using IHC and FISH. Anticancer research. 2024. 44. 2. 621-630
-
Huanyu Zheng, Ryouichi Tsunedomi, Ming Xu, Ying Zhang, Hiroko Kishi, Sei Kobayashi, Shinobu Tomochika, Masao Nakajima, Hiroto Matsui, Yukio Tokumitsu, et al. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis. Anticancer research. 2024. 44. 2. 511-520
ｍore...
MISC (236)：
-
兼定航, 恒富亮一, 硲彰一, 荻原宏是, 浜本義彦, 新藤芳太郎, 松井洋人, 徳光幸生, 吉田晋, 飯田通久, et al. イリノテカン毒性と関連するR3HCC1遺伝子における一塩基多型. 山口医学. 2023. 72. 3
-
硲 彰一, 玉田 耕治, 宇高 恵子, 加藤 直也, 坂元 亨宇, 土肥 俊, 中上 裕有樹, 中島 正夫, 松井 洋人, 徳光 幸生, et al. がん免疫療法 臨床研究の現状 新しいがん免疫療法 Cold tumorをHot tumorに. 日本がん免疫学会総会プログラム・抄録集. 2021. 25回. 64-64
-
松隈 聰, 徳光 幸生, 新藤 芳太郎, 松井 洋人, 中島 正夫, 藤本 拓也, 山田 健介, 木村 祐太, 中上 裕有樹, 渡邊 裕策, et al. 肝切除における腹腔鏡アプローチの導入は、術後感染性合併症軽減に寄与する. 日本外科学会定期学術集会抄録集. 2021. 121回. PS-4
-
木村 祐太, 徳光 幸生, 松隈 聰, 松井 洋人, 新藤 芳太郎, 中島 正夫, 吉田 晋, 飯田 通久, 鈴木 伸明, 武田 茂, et al. 門脈内腫瘍栓に対する肝動注化学療法と外科切除. 癌と化学療法. 2019. 46. 4. 760-762
-
恒富 亮一, 吉村 清, 松隈 聰, 西山 光郎, 兼清 信介, 徳光 幸生, 友近 忍, 飯田 通久, 鈴木 伸明, 武田 茂, et al. 誘導癌幹細胞における免疫逃避機構関連遺伝子の同定. 日本癌治療学会学術集会抄録集. 2018. 56回. P111-5
ｍore...
Lectures and oral presentations (1)：
-
Overexpression of miR221 and 222 in cancer stroma is associtated with malignant potentials in colorectal cancer
(UEGW 2015)
Education (1)：
- 2004 - 2009 Yamaguchi University Graduate School
Professional career (1)：
Work history (1)：
- 2006/04 - 2019/10 Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine Assistant professor
Return to Previous Page
